Wegovy Summary of Product Characteristics (SmPC), Section 4.8
Most patient will use Semaglutide for 6 months to at least one year, depending on their goals
We used real-world omics from the deCODE study to gain a better understanding about the effects of semaglutide on other disease processes other than obesity
Preserving metabolically active tissues supports physical function, sustains resting energy expenditure, and reduces the risk of rapid weight regain, thereby enhancing the long-term success and cost-effectiveness of obesity treatments [8, 22,23,24,25]
Blood donation can temporarily affect glucose levels, particularly if you take medicines that cause hypoglycaemia such as sulfonylureas